-
Study aim
-
Reducing the pain and suffering of labor, which encourages more mothers to deliver normal labor and reduce the stress of labor pain.
-
Design
-
This study is a randomized clinical trial (Randomized clinical trial) that is done in double blinds for all pregnant women referred to Taleghani hospital in Arak who are candidates for normal delivery.
In this study, 112 patients with normal delivery were randomly divided into two equal groups of epidural delivery with bupivacaine and rupivacaine.
-
Settings and conduct
-
For both groups of pregnant women, a questionnaire asking for demographic information, cesarean section and mean delivery phases is completed.
-
Participants/Inclusion and exclusion criteria
-
Entry requirements: single pregnant mothers and vaginal delivery candidates, mothers with grade 1 and grade 2 ASA, mothers between the weeks 42-37 who are perfectly graduated and have an epidural analgesic satisfaction
Conditions of failure to enter:failure in the epidural analgesia and pregnant mothers who are candidates for cesarean section for emergency reasons
-
Intervention groups
-
After obtaining informed consent, 112 pregnant women will be subjected to natural epidural analgesia (epidural analgesia) with bupivacaine or ropivacaine. After receiving 3-5 cc / kg of crystalloid fluid and placing the required monitoring in Sitting from L3-L4 or L4-L5 space using gage20 needle under epidural analgesia with bupivacaine or rupivacaine, then an epidural catheter is fixed. Patients use a 4-6 cc marcaine, 125.0% and 5 μg fentanyl as single dose block epidermis. For preservative dosage, the combination of marcaine is 125% and fentanyl% 002/0 is used at 6-10 cc / h.
-
Main outcome variables
-
Mean of motor blocker, mean of Apgar score of 1 and 5 neonates, mean of use of labor aid tools, mean satisfaction of patients, mean cesarean section, mean duration of second stage of labor, average active period of labor